ARTICLE | Management Tracks
Delfi promotes Buechel to president and COO
Plus: changes at Precision and updates for the TB Alliance and FDA
February 25, 2023 12:56 AM UTC
Delfi Diagnostics Inc. promoted COO Jenn Buechel to president and COO. The company is working to make liquid biopsy tests for the early detection of cancer less expensive and more accessible.
Gene editing company Precision BioSciences Inc. (NASDAQ:DTIL) announced a handful of changes to its senior leadership team, including the forthcoming departure of co-founder and CSO Derek Jantz, who will become chief science adviser. Co-founder Jeff Smith will lead the company’s research strategy and day-to day management of the research function as chief research officer, as previously announced. The company also promoted Neil Leatherbury to SVP, head of CMC. Leatherbury joined Precision in 2017...